John P. Sharp
Board Member
Cadrenal Therapeutics, Inc. (CVKD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John P. Sharp
John P. Sharp is recorded as CFO and Board Member at Cadrenal Therapeutics, Inc. (CVKD). Cadrenal Therapeutics, Inc. reported in an 8-K filed June 29, 2026 that John P. Sharp was appointed Interim Chief Financial Officer, effective June 25, 2026.
“On June 25, 2026, the Board of Directors (the "Board") of Cadrenal Therapeutics, Inc. (the "Company") appointed John P. Sharp as Interim Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-25–present
-
Current
2026-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cadrenal Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Jeffrey Cole COO, Board Member
- Class I Directors Board Member
- Glynn Wilson Board Member
- James J. Ferguson III Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Lee Scott Golden, M.D. Board Member
- Robert Lisicki Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.